Bibliography

Export 27 results:

Filters: Author is Penn,I. and Keyword is Kidney Transplantation [Clear All Filters]

1999

Penn I. Posttransplant malignancies. Transplant Proc. 1999;31(40575):1260-2.

1996

Penn I. Evaluation of the candidate with a previous malignancy. Liver Transpl Surg. 1996;2(5 Suppl 1):109-13.

1994

Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1994:99-109.

Penn I. The problem of cancer in organ transplant recipients: an overview. Transplant Sci. 1994;4(1):23-32.

1989

First MR, Schroeder TJ, Hurtubise PE, Mansour ME, Penn I, Munda R, et al. Successful retreatment of allograft rejection with OKT3. Transplantation. 1989;47(1):88-91.

1986

Penn I, First MR. Development and incidence of cancer following cyclosporine therapy. Transplant Proc. 1986;18(2 Suppl 1):210-5.

1983

Penn I. Kaposi's sarcoma in immunosuppressed patients. J Clin Lab Immunol. 1983;12(1):1-10.

House R, Dubovsky SL, Penn I. Psychiatric aspects of hepatic transplantation. Transplantation. 1983;36(2):146-50.

1981

Harris JP, Penn I. Immunosuppression and the development of malignancies of the upper airway and related structures. Laryngoscope. 1981;91(4):520-8.

1980

Penn I. Immunosuppression and skin cancer. Clin Plast Surg. 1980;7(3):361-8.

Penn I. Some contributions of transplantation to our knowledge of cancer. Transplant Proc. 1980;12(4):676-80.

1979

Penn I. Tumors in allograft recipients. N Engl J Med. 1979;301(7):385.

1978

Penn I. Development of cancer in transplantation patients. Adv Surg. 1978;12:155-91.

Penn I. Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery. 1978;83(5):492-502.

Penn I. Tumors arising in organ transplant recipients. Adv Cancer Res. 1978;28:31-61.

1977

Penn I. Development of cancer as a complication of clinical transplantation. Transplant Proc. 1977;9(1):1121-7.

1975

Penn I. Malignant disease in immunodeficient states in man. Recent Results Cancer Res. 1975;(52):96-106.

1974

Penn I. Chemical immunosuppression and human cancer. Cancer. 1974;34(4 Suppl):suppl:1474-80.

Husberg B, Penn I, Freedman HH. Evaluation of oxisuran as an immunosuppressive agent. Proc Soc Exp Biol Med. 1974;145(2):669-74.

Penn I. Malignancies in recipients of organ transplants. Johns Hopkins Med J Suppl. 1974;3:211-21.

1972

Starzl TE, Groth CG, Kashiwagi N, Putnam CW, Corman JL, Halgrimson CG, et al. Clinical experience with horse antihuman ALG. Transplant Proc. 1972;4(4):491-5.

Penn I, Starzl TE. Proceedings: The effect of immunosuppression on cancer. Proc Natl Cancer Conf. 1972;7:425-36.

1971

Starzl TE, Putnam CW, Halgrimson CG, Schroter GT, Martineau G, Launois B, et al. Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet. 1971;133(6):981-91.

1970

Coburg AJ, Gray SH, Katz FH, Penn I, Halgrimson C, Starzl TE. Disappearance rates and immunosuppression of intermittent intravenously administered prednisolone in rabbits and human beings. Surg Gynecol Obstet. 1970;131(5):933-42.

Starzl TE, Penn I, Halgrimson CG. Immunosuppression and malignant neoplasms. N Engl J Med. 1970;283(17):934.

Pages